adorable baby smiling with joy

Peds Calc

Pediatric Reference

Dimenhydrinate Side EffectsComprehensive Pediatric Safety Guide

Dimenhydrinate’s first-generation antihistamine properties cause sedation, anticholinergic effects, and, rarely, paradoxical agitation in young children.

3 Categories
6 Clinical Sources
Evidence-Based
Back to Dimenhydrinate Overview

Essential Information

1

Use the lowest effective dose and limit therapy to short courses for motion sickness or vestibular nausea.

2

Avoid concurrent sedatives (opioids, benzodiazepines) and counsel adolescents on the danger of combining with alcohol.

3

Monitor for paradoxical agitation, especially in toddlers and children with neurodevelopmental conditions.

Clinical Overview

Most adverse effects are mild and dose-related. Families should recognize signs of dehydration, urinary retention, and paradoxical CNS excitation.

Side Effect Categories

3 Systems

Neurologic

2 documented effects

Total Sources: 3

Drowsiness

Incidence: Common
Onset: Not specified
mild
1 sources
Duration

Not specified

Management

Schedule doses during travel or bedtime; advise supervision for activities requiring coordination (swimming, biking).

Monitoring Guidelines

Monitor for symptom escalation or new adverse effects.

1 clinical sources• PubMed • Clinical Guidelines • FDA

Paradoxical excitation (agitation, hallucinations)

Incidence: Uncommon
Onset: Not specified
serious
2 sources
Duration

Not specified

Management

Discontinue immediately and seek medical evaluation; more common in children <6 years.

Monitoring Guidelines

Monitor for symptom escalation or new adverse effects.

2 clinical sources• PubMed • Clinical Guidelines • FDA

Anticholinergic

2 documented effects

Total Sources: 2

Dry mouth and throat

Incidence: Common
Onset: Not specified
mild
1 sources
Duration

Not specified

Management

Offer sugar-free lozenges or water; monitor for dental hygiene impact.

Monitoring Guidelines

Monitor for symptom escalation or new adverse effects.

1 clinical sources• PubMed • Clinical Guidelines • FDA

Urinary retention

Incidence: Rare
Onset: Not specified
moderate
1 sources
Duration

Not specified

Management

Encourage regular voiding; seek care if child cannot urinate or develops suprapubic pain.

Monitoring Guidelines

Monitor for symptom escalation or new adverse effects.

1 clinical sources• PubMed • Clinical Guidelines • FDA

Gastrointestinal

1 documented effect

Total Sources: 1

Constipation

Incidence: Uncommon
Onset: Not specified
mild
1 sources
Duration

Not specified

Management

Increase fluids and fiber; consider stool softener if prolonged use is necessary.

Monitoring Guidelines

Monitor for symptom escalation or new adverse effects.

1 clinical sources• PubMed • Clinical Guidelines • FDA

Parent Communication Guide

Age-Appropriate Explanations

Infants (0-12 months)

For babies taking Dimenhydrinate, watch for signs of side effects. This medication is generally well-tolerated in infants when used as directed.

Toddlers (1-3 years)

If your toddler is taking Dimenhydrinate, they might feel different. This is usually temporary and normal.

Children (4-12 years)

This medicine may make you sleepy; sit down before you feel dizzy and tell us if your tummy or bladder hurts.

Adolescents (13+ years)

Take the smallest dose that works, avoid alcohol, and do not drive or operate bikes until you know how sleepy it makes you.

Common Parent Concerns

Q: Extreme sleepiness

A: Expected effect. Keep activities quiet, but call if your child is difficult to wake or breathing abnormally.

When to validate: Seek urgent care if unresponsive or breathing slowly.

Clinical Decision Support

Severity Assessment Framework

Clinical assessment framework for Dimenhydrinate adverse effects using standardized severity grading.

Mild
Indicators: Minimal symptoms, No functional impairment, Patient comfortable continuing
Action: Continue medication with supportive care and routine monitoring
Moderate
Indicators: Noticeable symptoms, Some functional impact, Patient/family concerned
Action: Consider dose adjustment, increase monitoring frequency, provide supportive care
Severe
Indicators: Significant symptoms, Functional impairment, Quality of life affected
Action: Consider discontinuation, evaluate alternatives, close clinical follow-up

Treatment Decision Guidelines

Immediate Discontinuation

  • Severe allergic reactions
  • Life-threatening adverse effects
  • Signs of toxicity

Consider Alternatives

  • Persistent moderate side effects
  • Inadequate therapeutic response
  • Patient/family preference

Dose Modification

  • Mild side effects with good efficacy
  • Age-related sensitivity
  • Drug interaction concerns

Clinical References

DimenhydrinateMedlinePlus (2024)Drug information
Dimenhydrinate for motion sicknessMedicines for Children (2024)Patient information

Frequently Asked Questions

Parent and clinician concerns about Dimenhydrinate